CME Group CME Cash Flow Statement
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| $4.27B+17.7% | $4.07B+15.5% | $3.76B+8.6% | $3.77B+14.1% | $3.63B+13.4% | ||
| $107.4M-4.4% | $107.5M-6.6% | $109.1M-7.3% | $110.9M-8.0% | $112.3M-9.6% | ||
| $95.4M+9.2% | $94.8M+5.9% | $93M+7.3% | $89.3M+4.7% | $87.4M+1.6% | ||
| —— | —— | -$71.9M-1.1% | -$72.6M-0.4% | -$66.4M+9.9% | ||
| —— | —— | —— | —— | —— | ||
| -$24.8M-128% | -$8.1M+24.3% | -$55M— | -$7.5M— | -$10.9M— | ||
| $164.6M+189% | $86.6M+112% | -$23.8M+82.0% | $53.4M+201% | -$184.7M-228% | ||
| —— | —— | —— | -$41.5M-146% | -$242.2M-206% | ||
| -$41M+27.3% | -$36.2M+34.7% | -$47.6M-180% | -$49.4M-57.8% | -$56.4M-93.8% | ||
| -$21.6M— | -$38.4M— | —— | —— | —— | ||
| —— | —— | —— | —— | $1.5M— | ||
| $224.3M+1.2% | $223.4M+0.8% | $222.8M+0.4% | $222.3M-0.5% | $221.7M-1.5% | ||
| $327.3M— | $352.8M— | —— | —— | —— | ||
| $4.42B+12.9% | $4.28B+15.9% | $4.16B+12.0% | $4.2B+17.5% | $3.91B+13.7% | ||
| $91.1M+3.1% | $83.5M-11.2% | $77.2M-12.9% | $88.6M+12.6% | $88.4M+9.1% | ||
| $3.8M-39.7% | $6M+33.3% | $5.1M-5.6% | $5.3M+17.8% | $6.3M+26.0% | ||
| $1.59B— | $1.59B— | —— | —— | —— | ||
| $1.49B+2,068% | $1.5B+1,915% | -$78.4M— | -$88.8M— | -$75.8M— | ||
| $4.06B+6.3% | $3.93B+9.7% | $3.9B+9.3% | $3.86B+8.8% | $3.82B+8.4% | ||
| —— | —— | —— | —— | $742.3M— | ||
| —— | —— | —— | —— | —— | ||
| $47.7M+65.1% | $33.9M+2.7% | $34.5M+6.5% | $29.4M-10.1% | $28.9M-13.5% | ||
| -$8.8M+5.4% | -$8.8M+4.3% | -$9M+49.7% | -$9.1M— | -$9.3M— | ||
| $39.41B— | $56.51B— | —— | —— | —— | ||
| $45.33B+73.1% | $62.29B+617% | $49.71B+473% | $56.68B+281% | $26.19B+170% | ||
| $140.8M+8.4% | $135.6M+4.4% | $135.6M+4.4% | $129.9M0.0% | $129.9M0.0% | ||
| $1.19B+9.1% | $1.16B-2.7% | $1.11B-1.2% | $1.13B+1.5% | $1.09B-5.3% | ||
| $224.3M+1.2% | $223.4M+0.8% | $222.8M+0.4% | $222.3M-0.5% | $221.7M-1.5% | ||
| —— | —— | —— | —— | —— | ||
| $327.3M— | $352.8M— | —— | —— | —— | ||
| $164.6M+189% | $86.6M+112% | -$23.8M+82.0% | $53.4M+201% | -$184.7M-228% | ||
| —— | —— | -$118.7M-66.0% | -$85.9M-42.0% | -$92.1M-27.2% | ||
| —— | —— | —— | -$41.5M-146% | -$242.2M-206% | ||
| -$21.6M— | -$38.4M— | —— | —— | —— | ||
| $10.1M— | $11M— | —— | —— | —— | ||
| $5.4M-31.6% | $7.9M+31.7% | $7.3M+14.1% | $7.5M+33.9% | $7.9M+14.5% | ||
| $77.18B+976% | $60.76B+598% | -$32.18B+68.6% | -$39.08B+37.5% | -$8.81B+84.4% | ||
| -$8.8M+5.4% | -$8.8M+4.3% | -$9M+49.7% | -$9.1M— | -$9.3M— | ||
| —— | —— | —— | —— | —— | ||
| —— | $750M— | $562.5M+13,620% | $375M+4,473% | $187.5M+1,424% | ||
| —— | $0-100% | $528.05M-74.4% | $1.06B-47.5% | $1.58B-19.2% | ||
| $4.33B+13.2% | $4.19B+16.6% | $4.08B+12.6% | $4.11B+17.6% | $3.83B+13.8% | ||
| $4.33B+13.2% | $4.19B+16.6% | $4.08B+12.6% | $4.11B+17.6% | $3.83B+13.8% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does CME Group generate?
- CME Group (CME) generated $4.4B in operating cash flow over the trailing twelve months.
- What is CME Group's free cash flow?
- After $91.1M of capital expenditures, CME Group's free cash flow was $4.3B over the trailing twelve months, up 13.2% year over year.
- Where does CME Group's cash flow data come from?
- Every line is extracted from CME Group's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
